Ativan and Squamous cell carcinoma - a phase IV clinical study of FDA data
Squamous cell carcinoma is found among people who take Ativan, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Ativan and have Squamous cell carcinoma. It is created by eHealthMe based on reports of 68,551 people who have side effects when taking Ativan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
68,551 people reported to have side effects when taking Ativan.
Among them, 121 people (0.18%) have Squamous cell carcinoma.
What is Ativan?
Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 72,590 Ativan users for its effectiveness, alternative drugs and more.
What is Squamous cell carcinoma?
Squamous cell carcinoma (a cancer of a kind of epithelial cell) is found to be associated with 1,282 drugs and 779 conditions by eHealthMe.
Number of Ativan and Squamous cell carcinoma reports submitted per year:
Time on Ativan when people have Squamous cell carcinoma *:
Gender of people who have Squamous cell carcinoma when taking Ativan*:
Age of people who have Squamous cell carcinoma when taking Ativan *:
Common drugs people take besides Ativan *:
Common side effects people have besides Squamous cell carcinoma *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ativan and have Squamous cell carcinoma?Check whether Squamous cell carcinoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Squamous cell carcinoma and when was it recovered:
Expand to all the drugs that have ingredients of lorazepam:
Alternative drugs to, pros and cons of Ativan:
- Ativan (72,590 reports)
Common Ativan side effects:
- Fatigue (feeling of tiredness): 7,778 reports
- Stress and anxiety: 6,626 reports
- Pain: 5,743 reports
- Diarrhea: 5,401 reports
- Weakness: 5,038 reports
Browse all side effects of Ativan:a b c d e f g h i j k l m n o p q r s t u v w x y z
Squamous cell carcinoma treatments and more:
- Squamous cell carcinoma (14,532 reports)
COVID vaccines that are related to Squamous cell carcinoma:
- Squamous cell carcinoma in Moderna COVID Vaccine
- Squamous cell carcinoma in Pfizer BioNTech Covid Vaccine
- Squamous cell carcinoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Squamous cell carcinoma:
- Prednisone: 963 reports
- Methotrexate: 923 reports
- Humira: 725 reports
- Aspirin: 692 reports
- Remicade: 674 reports
- Fosamax: 443 reports
- Enbrel: 438 reports
- Omeprazole: 387 reports
- Prednisolone: 380 reports
- Tacrolimus: 363 reports
All the drugs that are associated with Squamous cell carcinoma:
- Squamous cell carcinoma (1,282 drugs)
Common conditions associated with Squamous cell carcinoma:
- Rheumatoid arthritis: 1,156 reports
- Psoriasis: 881 reports
- High blood pressure: 668 reports
- Crohn's disease: 545 reports
- Osteoporosis: 429 reports
- Multiple sclerosis: 383 reports
- Multiple myeloma: 371 reports
- High blood cholesterol: 315 reports
- Pain: 294 reports
All the conditions that are associated with Squamous cell carcinoma:
- Squamous cell carcinoma (779 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lorazepam (the active ingredients of Ativan) and Ativan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Coreg vs. Cardizem Sr - 11 seconds ago
- Viibryd and Deep Venous Thrombosis - 13 seconds ago
- Biaxin vs. Claritin-D - 15 seconds ago
- Bisoprolol Fumarate And Hydrochlorothiazide vs. Timolol Maleate - 18 seconds ago
- Zyrtec vs. Ceclor - 20 seconds ago
- Bisacodyl vs. Magnesium Oxide - 20 seconds ago
- Carbidopa vs. Clonazepam - 22 seconds ago
- Rozerem and Urge Incontinence - 23 seconds ago
- Verapamil Hydrochloride vs. Caduet - 23 seconds ago
- Candesartan Cilexetil; Hydrochlorothiazide vs. Tiazac - 25 seconds ago